EUVIMEDEUVIMED entdecken
Crossref

CD133 + Lung Cancer Stem-like Cells Resist Plasma-activated Medium Through PRDX5-mediated Antioxidant Defense

Nan-Nan Yu, Yue Liu, Xiao-Yu Guo, Kee Kwang Kim, Ji Hye Kim, Taeho Kwon, Dong Hun Lee, Hu-Nan Sun

Anticancer Research · 2026

DOI: 10.21873/anticanres.18030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Nan-Nan Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science and Technology, Heilongjiang Bayi Agricultural University, Daqing, P.R. China. Hauptthemen laut MEDLINE: Peroxiredoxins, AC133 Antigen, Neoplastic Stem Cells, Lung Neoplasms.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeroxiredoxinsAC133 AntigenNeoplastic Stem CellsLung NeoplasmsCarcinoma, Non-Small-Cell LungAntioxidantsPlasma GasesHumansAnimalsReactive Oxygen SpeciesMiceApoptosisXenograft Model Antitumor AssaysOxidative StressA549 Cells

Stichwörter der Autor:innen

Plasma-activated mediumcancer stem cellsoxidative damageperoxiredoxin 5

Substanzen

PeroxiredoxinsAC133 AntigenReactive Oxygen SpeciesPROM1 protein, humanPRDX5 protein, humanAntioxidantsPlasma Gases

Autor:innen und Institutionen

  • College of Life Science and Technology, Heilongjiang Bayi Agricultural University, Daqing, P.R. China.
  • Heilongjiang Provincial Key Laboratory of Animal Cell Activities and Stress Adaptations, Daqing, P.R. China.
  • Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.
  • Department of Biochemistry, College of Natural Sciences, Chungnam National University, Daejeon, Republic of Korea.
  • Department of Biological Sciences, Chonnam National University, Gwangju, Republic of Korea.
  • Futuristic Animal Resource and Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju, Republic of Korea; kwon@kribb.re.kr.

Zitieren

APA

Yu, N. N., Liu, Y., Guo, X. Y., Kim, K. K., Kim, J. H., Kwon, T., Lee, D. H., & Sun, H. N. (2026). CD133 + Lung Cancer Stem-like Cells Resist Plasma-activated Medium Through PRDX5-mediated Antioxidant Defense. Anticancer Research. https://doi.org/10.21873/anticanres.18030

Vancouver

Yu NN, Liu Y, Guo XY, Kim KK, Kim JH, Kwon T, et al. CD133 + Lung Cancer Stem-like Cells Resist Plasma-activated Medium Through PRDX5-mediated Antioxidant Defense. Anticancer Research. 2026. doi:10.21873/anticanres.18030

BibTeX
@article{Yu2026,
  author = {Yu, Nan-Nan and Liu, Yue and Guo, Xiao-Yu and Kim, Kee Kwang and Kim, Ji Hye and Kwon, Taeho and Lee, Dong Hun and Sun, Hu-Nan},
  title = {CD133 + Lung Cancer Stem-like Cells Resist Plasma-activated Medium Through PRDX5-mediated Antioxidant Defense},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.18030}
}
Kostenlos starten →